Global Dextran Market growing at a CAGR of 5.1% from 2023 to 2030
Category : Healthcare | Published Date : Aug 2023 | Type : Press Release | Author : Swapnil Bakshetty
Key Market Overview
Consegic Business Intelligence analyzes that the dextran market is predicted to grow at a compound annual growth rate of 5.1% from 2023 to 2030 and is expected to reach USD 322.34 million in 2030 which was valued at USD 216.87 million in 2022.
The report highlights the increasing demand for dextran for the treatment of various medical conditions, which is proliferating market growth. Consegic Business Intelligence study also provides insights into the market's competitive landscape, market segmentation, regional outlook, and emerging technologies in the dextran market.
Global Dextran Market By Overview
The dextran market is bifurcated into the type, application, and end-use industry. The type segment is categorized into Dextran 20, Dextran 40, Dextran 60, Dextran 70, and Others. In 2022, the dextran 70 segment accounted for the highest market share in the dextran market. Based on application the market is segmented into solutions for injection and infusion, dextran derivatives, additives, and others. In 2022, the dextran derivatives segment dominates the overall dextran market. The end-use industry segment is categorized into pharmaceutical, food & beverages, agriculture, cosmetics, and others. In 2022, the pharmaceutical segment accounted for the highest market share in the dextran market.
Get Free SampleMarket Dynamics
Driver:
- Increasing demand for dextran for the treatment of various medical conditions is benefiting the market growth.
- Rising demand for dextran as an anti-platelet drug
Restraints:
- Increasing side effects associated with the use of dextran.
Market Segmentation:
| Report Attributes | Report Details |
| By Type | Dextran 20, Dextran 40, Dextran 60, Dextran 70, and Others |
| By Application | Solutions for Injection and Infusion, Dextran Derivatives, Additives, and Others |
| By End-use Industry | Pharmaceutical, Food & Beverages, Agriculture, Cosmetics, and Others |
| By Region | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Competitive Landscape :
As per the study, the market is dominated by certain major companies such as Pharmacosmos A/S, PK Chemicals, Meito Sangyo, and Polydex Pharmaceuticals Limited which has a strong market position in current market circumstances. These companies are continuously leveraging new technologies to develop innovative solutions that are more durable, ensure superior functioning, and others. Furthermore, the dextran market is expected to witness substantial growth in the coming years due to the significant growth in the pharmaceutical industry in key regions such as North America, Asia Pacific, and others.
The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships.
- Pharmacosmos A/S
- PK Chemicals
- Meito Sangyo
- Polydex Pharmaceuticals Limited
- Jinyang Pharmaceuticals
- Tianxiangyuan
- Pfizer
- Megazyme Ltd.
- Merck KGaA
- Fencheng Group Co., Ltd.
Our Clients
